China to cut VAT for rare disease drugs

An executive meeting of China’s State Council outlined plans to reduce the value-added tax on domestic and imported rare disease drugs, improve cancer treatment and accelerate approval of cancer therapies.

Beginning March 1, the government will reduce the VAT on a "first batch" of 21 rare disease drugs and four APIs to 3% from 16%. The affected drugs were not identified...